
Overview
Dr. Lister is Chief of the Division of Hematology and Cellular Therapy, AHN Cancer Institute. He is an experienced transplant physician who participated in his first bone marrow transplant in 1979. Since that time, he has been involved in more than a thousand transplants and has contributed to many clinical studies and made original contributions in the literature. Dr. Lister received his initial exposure to marrow transplantation as a trainee at McGill University and received further training at the Fred Hutchinson Cancer Research Center in Seattle. Subsequently, as Terry Fox Fellow of the National Cancer Institute of Canada, he received additional clinical and laboratory training in marrow transplantation at the Ontario Cancer Institute/Princess Margaret Hospital at the University of Toronto. He returned to McGill and actively participated in transplant for the next five years before accepting a position in the Division of Hematology and Bone Marrow Transplantation at The University of Pittsburgh. In 1997, he joined the faculty at West Penn Hospital. Dr. Lister is a Professor of Medicine, Temple University School of Medicine, and serves on numerous scientific and administrative committees, including the Lymphoma Committee of the CIBMTR. He is a member of the Board of Trustees for the Leukemia and Lymphoma Society of Western Pennsylvania.
Dr. Lister is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Multiple Myeloma, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration.
Dr. Lister is board certified in American Board Of Internal Medicine - Hematology and Medical Oncology, American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 37 peer reviewed articles and participating in 5 clinical trials.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4815 Liberty Avenue, Pittsburgh, PA 15224
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Classical Hematology
Enrico M. Novelli, MD, is a classical (benign) hematologist, the Chief of the Section of Benign Hematology, and the medical director of the UPMC Adult Sickle Cell Disease Program. Board-certified in hematology, Dr. Novelli received his medical degree from the University of Milan, Italy. He completed his residency in internal medicine and fellowship in hematology-oncology at UPMC. Dr. Novelli specializes in sickle cell anemia and hemoglobinopathies. Dr. Novelli is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, and Hemoglobinopathy. Dr. Novelli is board certified in American Board Of Internal Medicine. Dr. Novelli is currently accepting new patients.
Univ. Of Pittsburgh Cancer Institute Cancer Services
Mounzer Agha is a Hematologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Agha is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Agha is currently accepting new patients.
Upmc Division Of Surgical Oncology
Diwakar Davar, MBBS, M.Sc is an assistant professor of medicine and a medical oncologist/hematologist. He specializes in the management of advanced melanoma and the development of early phase studies to test novel immunotherapeutic approaches to treat advanced cancers.;. Dr. Davar is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Metastatic Uveal Melanoma, Uveal Melanoma, and Gamma Knife Radiosurgery. Dr. Davar is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Davar is currently accepting new patients.
Classical Hematology
Craig Seaman is a Hematologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Seaman is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Von Willebrand Disease (VWD), Hemophilia A, Blood Clots, and Hemophilic Arthropathy. Dr. Seaman is board certified in American Board Of Internal Medicine. Dr. Seaman is currently accepting new patients.
AHN Cancer Institute-Med Onc & Infusions At Allegheny General Hospital
Dr. Dulabh K. Monga is an Associate Professor of Medicine at Drexel University School of Medicine. She has been a GI Medical Oncologist practicing for the past 20 years. She is the lead for the Pancreas Cancer Disease Site Leadership Program at Allegheny Health Network and the Director of the Annual Pancreas Symposium. Dr. Monga is closely involved with the Cancer Bridges Support Group Program. She has done extensive clinical research and published original research, review articles and abstracts and mentored residents and fellows with their scholarly projects. She has served as the Principal Investigator for numerous clinical trials. She served as the Program Director of the Hematology Oncology Fellowship Program for 11 years. Dr. Monga has a passion for teaching medical students, residents and fellows and has been recognized for her dedication, mentorship, and excellence in teaching multiple times. Her passion is providing high quality multidisciplinary care that brings not only the best outcomes but maintains the quality of life of patients with pancreas cancer and other GI malignancies. She was awarded the Clinical Excellence Award from the National Pancreas Foundation in 2025. Dr. Monga has been named “Top Doctor” as chosen by her peers and featured in Pittsburgh Magazine for 2024 and 2025. Dr. Monga is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Monga is board certified in Medical Oncology, American Board Of Internal Medicine.
Mario Lemieux Center For Blood Cancers
Anastasios Raptis is a Hematologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Raptis is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
Frequently Asked Questions about Dr. John W. Lister
How do I make an appointment with Dr. John W. Lister?
You can book an appointment with Dr. John W. Lister by calling their office at 412-578-4484. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. John W. Lister a top-rated expert for Acute Myeloid Leukemia (AML)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. John W. Lister is classified as an Distinguished expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. John W. Lister specialize in?
While Dr. John W. Lister is a Hematology, they have specific expertise in Acute Myeloid Leukemia (AML), Multiple Myeloma, and Acute Myeloblastic Leukemia without Maturation. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. John W. Lister participate in research or clinical trials?
Yes. Dr. John W. Lister has published 37 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Dr. John W. Lister's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. John W. Lister accept my insurance?
Dr. John W. Lister accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 412-578-4484 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Lister isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Multiple MyelomaDr. Lister isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Aplastic AnemiaDr. Lister isAdvanced. Learn about Aplastic Anemia.
- Childhood Acute Myeloid LeukemiaDr. Lister isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic B-Cell Leukemia (CBCL)Dr. Lister isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelogenous Leukemia (CML)
- Classical Hodgkin LymphomaDr. Lister isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Cutaneous T-Cell Lymphoma (CTCL)Dr. Lister isAdvanced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Febrile NeutropeniaDr. Lister isAdvanced. Learn about Febrile Neutropenia.
- Follicular LymphomaDr. Lister isAdvanced. Learn about Follicular Lymphoma.
- Large-Cell Immunoblastic LymphomaDr. Lister isAdvanced. Learn about Large-Cell Immunoblastic Lymphoma.
- Mantle Cell Lymphoma (MCL)Dr. Lister isAdvanced. Learn about Mantle Cell Lymphoma (MCL).
- Non-Hodgkin LymphomaDr. Lister isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Peripheral T-Cell LymphomaDr. Lister isAdvanced. Learn about Peripheral T-Cell Lymphoma.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Relapsed Refractory Multiple Myeloma (RRMM)
- Richter SyndromeDr. Lister isAdvanced. Learn about Richter Syndrome.
- T-Cell LymphomaDr. Lister isAdvanced. Learn about T-Cell Lymphoma.
- Experienced
- Acute Eosinophilic PneumoniaDr. Lister isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Lymphoblastic Leukemia (ALL)Dr. Lister isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myelomonocytic LeukemiaDr. Lister isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Acute Promyelocytic LeukemiaDr. Lister isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult Immune ThrombocytopeniaDr. Lister isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult T-Cell LeukemiaDr. Lister isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Lister isExperienced. Learn about Agranulocytosis.
- Anaplastic Large Cell LymphomaDr. Lister isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Angioimmunoblastic T-cell LymphomaDr. Lister isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- B-Cell LymphomaDr. Lister isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow AspirationDr. Lister isExperienced. Learn about Bone Marrow Aspiration.
- Bone Marrow TransplantDr. Lister isExperienced. Learn about Bone Marrow Transplant.
- Chronic Myelomonocytic Leukemia (CMML)Dr. Lister isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Chronic T-Cell Leukemia (CTCL)Dr. Lister isExperienced. Learn about Chronic T-Cell Leukemia (CTCL).
- Gastric LymphomaDr. Lister isExperienced. Learn about Gastric Lymphoma.
- Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency
- Graft Versus Host Disease (GvHD)Dr. Lister isExperienced. Learn about Graft Versus Host Disease (GvHD).
- GTP Cyclohydrolase 1 DeficiencyDr. Lister isExperienced. Learn about GTP Cyclohydrolase 1 Deficiency.
- Hairy Cell Leukemia (HCL)Dr. Lister isExperienced. Learn about Hairy Cell Leukemia (HCL).
- Hemangioma Thrombocytopenia SyndromeDr. Lister isExperienced. Learn about Hemangioma Thrombocytopenia Syndrome.
- Hodgkin LymphomaDr. Lister isExperienced. Learn about Hodgkin Lymphoma.
- Hypereosinophilic SyndromeDr. Lister isExperienced. Learn about Hypereosinophilic Syndrome.
- Immune Thrombocytopenic Purpura (ITP)Dr. Lister isExperienced. Learn about Immune Thrombocytopenic Purpura (ITP).
- LeukemiaDr. Lister isExperienced. Learn about Leukemia.
- Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
- Myelodysplastic Syndrome (MDS)Dr. Lister isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Primary Lymphoma of the BrainDr. Lister isExperienced. Learn about Primary Lymphoma of the Brain.
- Pseudocholinesterase DeficiencyDr. Lister isExperienced. Learn about Pseudocholinesterase Deficiency.
- Pure Red Cell AplasiaDr. Lister isExperienced. Learn about Pure Red Cell Aplasia.
- ReticuloendotheliosisDr. Lister isExperienced. Learn about Reticuloendotheliosis.
- Small Lymphocytic Lymphoma (SLL)Dr. Lister isExperienced. Learn about Small Lymphocytic Lymphoma (SLL).
- Smoldering Multiple MyelomaDr. Lister isExperienced. Learn about Smoldering Multiple Myeloma.
- Systemic MastocytosisDr. Lister isExperienced. Learn about Systemic Mastocytosis.
- ThrombocytopeniaDr. Lister isExperienced. Learn about Thrombocytopenia.
- Transient Erythroblastopenia of Childhood



